Abbott | ABT - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Abbott USD 3.27B 138M 2026-03
Agilent USD 465M 11M 2026-03
AtriCure USD 84.55M 6.21M 2026-03
Baxter International USD 728M 33M 2026-03
Becton, Dickinson and Co. USD 1.21B 180M 2026-03
Bio-Rad Laboratories USD 221M 14.2M 2025-12
Boston Scientific USD 1.78B 53M 2026-03
Cooper Companies USD 676.2M 303.1M 2026-03
Danaher USD 1.86B 166M 2026-03
Dexcom USD 349.7M 49.8M 2026-03
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Globus Medical USD 297.77M 20.7M 2026-03
Insulet USD 317.2M 14.2M 2026-03
Integra LifeSciences USD 178.24M 21.79M 2026-03
Intuitive Surgical USD 613.3M 73.8M 2026-03
J&J USD 6.03B 719M 2026-03
Medtronic 2.96B 9M 2025-12
Merit Medical Systems USD 110.47M 4.36M 2026-03
Pfizer USD 2.92B 1.16B 2026-03
Smith & Nephew USD 1.42B 65M 2025-12
Solventum Corp USD 783M 24M 2026-03
Stryker USD 2.15B 17M 2026-03
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 226.01M 3.64M 2026-03
Terumo JPY 114.81B 9.55B 2026-03
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Zimmer Biomet Holdings USD 849.9M 5.8M 2026-03